Innervace
Develops regenerative therapy solutions for neurodegenerative disorders.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD247—371m (Dealroom.co estimates Sep 2022.)
Philadelphia Pennsylvania (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
* | $40.0m | Series A | |
| Total Funding | AUD61.8m | ||